普洛药业：与西安新通药物研究股份有限公司签订战略合作框架协议

Core Viewpoint - The company has signed a strategic cooperation framework agreement with Xi'an New Tong Pharmaceutical Research Co., Ltd. to engage in long-term collaboration on innovative drug research and development as well as outsourced custom manufacturing projects [1] Group 1: Agreement Details - The agreement is a framework agreement and does not involve substantial transactions or constitute a major asset restructuring [1] - The collaboration is expected to benefit the company's CDMO (Contract Development and Manufacturing Organization) business expansion and enhance its competitive edge [1] Group 2: Financial Impact - The agreement is not expected to have a significant impact on the company's operating performance for the current fiscal year [1] - Future performance implications will depend on subsequent specific project agreements and their implementation [1]